Skip to main content
Clinical Trials/CTRI/2024/05/067399
CTRI/2024/05/067399Not yet recruitingPhase 3

Intrathecal hyperbaric bupivacaine versus hyperbaric ropivacaine in spinal anaesthesia in caesarean sections: a randomised control trial in a teaching hospital in northeast India. - Nil

eon0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • i.All patients who will be registered for elective caesarean delivery and belonging to ASA (American Society of Anesthesiologists) grade I & II only.
  • ii.Patients between 145to 165 cms of height.
  • iii.Patients who will give valid informed written consent.
  • iv.Pregnancy over 37 weeks and less than 42 weeks.
  • v.Patient with weight of 45-95kgs.
  • vi.Patients with age between 18years and 40 years.

Exclusion Criteria

  • i.Patient with abnormalities and problems in the embryo.
  • ii.Patient with indication of an emergency caesarean section.
  • iii.Patients having history of hypersensitivity to anesthetic agents.
  • iv.Infection at the subarachnoid block injection site.
  • v.Pre-term and post term delivery.
  • vi.ASA class higher than II.

Investigators

Sponsor
eon

Similar Trials